메뉴 건너뛰기




Volumn 92, Issue 3, 2004, Pages 568-574

Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass

Author keywords

Aprotinin; Cardiopulmonary bypass; Fibrinolysis; Haemostasis; Kallikrein inhibitor

Indexed keywords

ALPHA 2 ANTIPLASMIN; APROTININ; D DIMER; KALLIKREIN INHIBITOR; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 4544279086     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-07-0455     Document Type: Article
Times cited : (36)

References (33)
  • 1
    • 15644382459 scopus 로고    scopus 로고
    • Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors
    • Northern New England Cardiovascular Disease Study Group
    • Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 1998; 133: 442-7.
    • (1998) Arch. Surg. , vol.133 , pp. 442-447
    • Dacey, L.J.1    Munoz, J.J.2    Baribeau, Y.R.3
  • 2
    • 0028946605 scopus 로고
    • Resternotomy for bleeding after cardiac operation: A marker for increase morbidity and mortality
    • Unsworth-White MJ, Herriot A, Valencia O. Resternotomy for bleeding after cardiac operation: a marker for increase morbidity and mortality. Ann Thorac Surg 1995; 59: 664-7.
    • (1995) Ann. Thorac. Surg. , vol.59 , pp. 664-667
    • Unsworth-White, M.J.1    Herriot, A.2    Valencia, O.3
  • 3
    • 0031960143 scopus 로고    scopus 로고
    • Management of bleeding complications in redo cardiac operations
    • Smith CR. Management of bleeding complications in redo cardiac operations. Ann Thorac Surg 1998; 65: 2-8.
    • (1998) Ann. Thorac. Surg. , vol.65 , pp. 2-8
    • Smith, C.R.1
  • 5
    • 0026793447 scopus 로고
    • Early activation of hemostasis during cardiopulmonary bypass: Evidence for thrombin mediated hyperfibrinolysis
    • Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68: 250-2.
    • (1992) Thromb. Haemost. , vol.68 , pp. 250-252
    • Teufelsbauer, H.1    Proidl, S.2    Havel, M.3
  • 6
    • 0025230919 scopus 로고
    • Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding
    • Gram J, Janetzko T, Jespersen J, et al. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990; 63: 241-5.
    • (1990) Thromb. Haemost. , vol.63 , pp. 241-245
    • Gram, J.1    Janetzko, T.2    Jespersen, J.3
  • 7
    • 0019180607 scopus 로고
    • Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transident platelet dysfunktion associated with selective alpha-granule release
    • Harker LA, Malpass TW, Branson HE, et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transident platelet dysfunktion associated with selective alpha-granule release. Blood 1980; 56: 824-34.
    • (1980) Blood , vol.56 , pp. 824-834
    • Harker, L.A.1    Malpass, T.W.2    Branson, H.E.3
  • 8
    • 0023058864 scopus 로고
    • Bleeding after cardiopulmonary bypass
    • Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: 446-8.
    • (1986) N. Engl. J. Med. , vol.314 , pp. 446-448
    • Harker, L.A.1
  • 9
    • 0024509887 scopus 로고
    • Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (trasylol)
    • Bidstrup BP, Royston D, Sapstord RN, et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (trasylol). J Thorac Cardiovasc Surg 1989; 97: 364-72.
    • (1989) J. Thorac. Cardiovasc. Surg. , vol.97 , pp. 364-372
    • Bidstrup, B.P.1    Royston, D.2    Sapstord, R.N.3
  • 10
    • 0028079871 scopus 로고
    • Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding
    • Fremes SE, Wong BI, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994; 58: 1580-8.
    • (1994) Ann. Thorac. Surg. , vol.58 , pp. 1580-1588
    • Fremes, S.E.1    Wong, B.I.2    Lee, E.3
  • 11
    • 0031415922 scopus 로고    scopus 로고
    • Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
    • for The International Study of Peri-operative Transfusion (ISPOT) Investigators
    • Laupacis A, Fergusson D, for The International Study of Peri-operative Transfusion (ISPOT) Investigators. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997; 85: 1258-67.
    • (1997) Anesth. Analg. , vol.85 , pp. 1258-1267
    • Laupacis, A.1    Fergusson, D.2
  • 12
    • 0033524140 scopus 로고    scopus 로고
    • Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
    • Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940-7.
    • (1999) Lancet , vol.354 , pp. 1940-1947
    • Levi, M.1    Cromheecke, M.E.2    de Jonge, E.3
  • 13
    • 0025992843 scopus 로고
    • Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary Bypass
    • Blauhaupt B, Gross C, Necek S, et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary Bypass. J Thorac Cardiovasc Surg 1991; 101: 958-67.
    • (1991) J. Thorac. Cardiovasc. Surg. , vol.101 , pp. 958-967
    • Blauhaupt, B.1    Gross, C.2    Necek, S.3
  • 14
    • 0027216882 scopus 로고
    • Mechanism of the preserving effect of aprotinin on platelet function and its use in cardic surgery
    • Huang H, Ding W, Su W, et al. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardic surgery. J Thorac Cardiovasc Surg 1993; 106: 11-8.
    • (1993) J. Thorac. Cardiovasc. Surg. , vol.106 , pp. 11-18
    • Huang, H.1    Ding, W.2    Su, W.3
  • 15
    • 0028311431 scopus 로고
    • Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss: Results of a double-blind randomized clinical trial
    • Kallis P, Tooze JA, Talbot S, et al. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss: results of a double-blind randomized clinical trial. Eur J Cardiothorac Surg 1994; 8: 315-23.
    • (1994) Eur. J. Cardiothorac. Surg. , vol.8 , pp. 315-323
    • Kallis, P.1    Tooze, J.A.2    Talbot, S.3
  • 16
    • 0028965954 scopus 로고
    • One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery- effect of Aprotinin
    • Mannucci L, Gerometta PS, Mussoni L, et al. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery- effect of Aprotinin. Thromb Haemost 1995; 73: 356-61.
    • (1995) Thromb. Haemost. , vol.73 , pp. 356-361
    • Mannucci, L.1    Gerometta, P.S.2    Mussoni, L.3
  • 17
    • 0029195783 scopus 로고
    • Suppressed fibrinolysis after administration of low-dose aprotinin: Reduced level of plasmin-alpha-2-plasmin inhibitor complexes and postoperative blood loss
    • Mastroroberto P, Chello M, Zofrea S, et al. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha-2-plasmin inhibitor complexes and postoperative blood loss. Eur J Cardio-Thorac Surg 1995; 9: 143-5.
    • (1995) Eur. J. Cardio-Thorac. Surg. , vol.9 , pp. 143-145
    • Mastroroberto, P.1    Chello, M.2    Zofrea, S.3
  • 18
    • 0025995998 scopus 로고
    • The effects of aprotinin on hemostatic function during cardiac surgery
    • Marx G, Pokar H, Reuter H, et al. The effects of aprotinin on hemostatic function during cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5: 467-74.
    • (1991) J. Cardiothorac. Vasc. Anesth. , vol.5 , pp. 467-474
    • Marx, G.1    Pokar, H.2    Reuter, H.3
  • 19
    • 0034848241 scopus 로고    scopus 로고
    • Low-dose postoperative aprotinin reduces mediastional drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: A prospective randomized, double-blind, placebo-controlled trial
    • Alvarez JM, Jackson LR, Chatwin C, et al. Low-dose postoperative aprotinin reduces mediastional drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 2001; 122: 457-63.
    • (2001) J. Thorac. Cardiovasc. Surg. , vol.122 , pp. 457-463
    • Alvarez, J.M.1    Jackson, L.R.2    Chatwin, C.3
  • 20
    • 0029798742 scopus 로고    scopus 로고
    • Aprotinin in primary valve replacement and reconstuction: A multicenter, double-blind, placebo-controlld trial
    • D'Ambra, MN, Akins CW, Blackstone EH, et al. Aprotinin in primary valve replacement and reconstuction: a multicenter, double-blind, placebo-controlld trial. J Thorac Cardiovasc Surg 1996; 112: 1081-9.
    • (1996) J. Thorac. Cardiovasc. Surg. , vol.112 , pp. 1081-1089
    • D'Ambra, M.N.1    Akins, C.W.2    Blackstone, E.H.3
  • 21
    • 0027818956 scopus 로고
    • Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients
    • Hardy JF, Desroches J, Belisle S, et al. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients. Can J Anaesth 1993; 40: 625-31.
    • (1993) Can. J. Anaesth. , vol.40 , pp. 625-631
    • Hardy, J.F.1    Desroches, J.2    Belisle, S.3
  • 22
    • 10544236908 scopus 로고    scopus 로고
    • Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens
    • Lemmer JH Jr, Dilling EW, Morton JR, et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. Ann Thorac Surg 1996; 62: 1659-68.
    • (1996) Ann. Thorac. Surg. , vol.62 , pp. 1659-1668
    • Lemmer Jr., J.H.1    Dilling, E.W.2    Morton, J.R.3
  • 24
    • 0029729898 scopus 로고    scopus 로고
    • Aprotinin: Safe and effective only with the full-dose regimen
    • (editoral)
    • Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen (editoral). Ann Thorac Surg 1996; 62: 1575-7.
    • (1996) Ann. Thorac. Surg. , vol.62 , pp. 1575-1577
    • Smith, P.K.1    Muhlbaier, L.H.2
  • 26
    • 0027415362 scopus 로고
    • Topical use of aprotinin in open heart operation
    • Tatar H, Cicek S, Demirkilic U, et al. Topical use of aprotinin in open heart operation. Ann Thorac Surg 1993; 55: 659-61.
    • (1993) Ann. Thorac. Surg. , vol.55 , pp. 659-661
    • Tatar, H.1    Cicek, S.2    Demirkilic, U.3
  • 27
    • 4544281222 scopus 로고
    • High-dose aprotinin therapy: A review of the first five years' experience
    • Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth 1991; 5: 467-74.
    • (1991) J. Cardiothorac. Vasc. Anesth. , vol.5 , pp. 467-474
    • Royston, D.1
  • 28
    • 0027435353 scopus 로고
    • Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass
    • Tabuchi N, de Haan J, Boonstra PW, et al. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 828-33.
    • (1993) J. Thorac. Cardiovasc. Surg. , vol.106 , pp. 828-833
    • Tabuchi, N.1    de Haan, J.2    Boonstra, P.W.3
  • 29
    • 0028840040 scopus 로고
    • Topical effect of aprotinin on surgical wound in cardiac surgery
    • (letter to the editor, reply to the editor)
    • Tabuchi N, de Haan J, van Oeveren W. Topical effect of aprotinin on surgical wound in cardiac surgery (letter to the editor, reply to the editor). J Thorac Cardiovasc Surg 1995; 109: 399-400.
    • (1995) J. Thorac. Cardiovasc. Surg. , vol.109 , pp. 399-400
    • Tabuchi, N.1    de Haan, J.2    van Oeveren, W.3
  • 30
    • 0027716817 scopus 로고
    • Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during reperfusion of shed blood after cardiopulmonary bypass
    • de Hann J, Schönberger JPAM, Haan J, et al. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during reperfusion of shed blood after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1017-23.
    • (1993) J. Thorac. Cardiovasc. Surg. , vol.106 , pp. 1017-1023
    • de Hann, J.1    Schönberger, J.P.A.M.2    Haan, J.3
  • 31
    • 0033866107 scopus 로고    scopus 로고
    • Aprotinin adninistration in the pericardial cavity does not prevent platelet activation
    • Maquelin KN, Nieuwland R, Lentjes EGWM, et al. Aprotinin adninistration in the pericardial cavity does not prevent platelet activation. J Thorac Cardiovasc Surg. 2000; 120: 552-7.
    • (2000) J. Thorac. Cardiovasc. Surg. , vol.120 , pp. 552-557
    • Maquelin, K.N.1    Nieuwland, R.2    Lentjes, E.G.W.M.3
  • 32
    • 4544271347 scopus 로고
    • Gerinnungsanalysen: Interpretation, Schnellorientierung, Therapiekontrollen. Stuttgart, New York, Thieme
    • Barthels M, Poliwoda H. Gerinnungsanalysen: Interpretation, Schnellorientierung, Therapiekontrollen. Stuttgart, New York, Thieme; 1993.
    • (1993)
    • Barthels, M.1    Poliwoda, H.2
  • 33
    • 0029049246 scopus 로고
    • Topical use of aprotinin in cardiac surgery (letter to the editor)
    • Cicek S, Tatar H, Demirkilic U, et al. Topical use of aprotinin in cardiac surgery (letter to the editor). J Thorac Cardiovasc Surg 1995; 110: 568-9.
    • (1995) J. Thorac. Cardiovasc. Surg. , vol.110 , pp. 568-569
    • Cicek, S.1    Tatar, H.2    Demirkilic, U.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.